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INTRODUCTION 
 
Circadian rhythms occur with a periodicity of about 24 
hours  and  regulate  a  wide  array  of  metabolic  and 
physiologic functions. A robust circadian clock allows 
organisms to anticipate environmental changes and to 
adapt their behavior and physiology to the appropriate 
time  of  day.  Disturbances  in  the  functionality  of  this 
“body  clock”  have  been  shown  to  lead  to  various 
diseases, such as sleep disorders, depression, metabolic 
syndrome  and  cancer  [1,2].  Circadian  rhythms  are 
regulated  by  transcriptional  and  post-translational 
feedback loops generated by a set of interplaying clock 
proteins.    The  transcription  factors  CLOCK  and 
BMAL1 operate as the master regulators of the clock 
machinery.  CLOCK:BMAL1  heterodimers  bind  to 
promoters  of  clock  controlled  genes  (CCGs)  and 
regulate their expression. Some CCGs are special in the 
sense that they encode other core-clock regulators, such 
as  Period  and  Cryptochrome  genes,  which negatively 
feedback on the clock machinery  [1-3]. Recently, the 
deacetylase  sirtuin  1  (SIRT1)  was  identified  as  a 
modulator  of  the  circadian  clock  machinery  that 
counterbalances  the  acetyltransferase  activity  of 
CLOCK  [4-7].  Moreover,  an  additional  novel 
transcriptional/enzymatic  feedback  loop  that  regulates 
the circadian clock has recently been uncovered [8,9]. 
The  circadian  clock  controls  the  levels  of  NAD
+  by 
regulating  the  expression  of  nicotinamide 
phosphoribosyltransferase  (NAMPT),  the  rate-limiting 
enzyme in the salvage pathway of NAD
+ biosynthesis 
[8,9].  NAD
+  is  also  synthesized  from  the  amino  acid 
tryptophan  by  the  de  novo  synthesis  pathway. 
Tryptophan  levels  have  been  shown  to  oscillate  in 
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Abstract: The Intracellular levels of nicotinamide adenine dinucleotide (NAD
+) are rhythmic and controlled by the 
circadian clock. However, whether NAD
+ oscillation in turn contributes to circadian physiology is not fully understood. 
To address this question we analyzed mice mutated for the NAD
+ hydrolase CD38. We found that rhythmicity of NAD
+ 
was altered in the CD38-deficient mice. The high, chronic levels of NAD
+ results in several anomalies in circadian 
behavior and metabolism. CD38-null mice display a shortened period length of locomotor activity and alteration in the 
rest-activity rhythm. Several clock genes and, interestingly, genes involved in amino acid metabolism were deregulated 
in  CD38-null  livers.  Metabolomic  analysis  identified  alterations  in  the  circadian  levels  of  several  amino  acids, 
specifically tryptophan levels were reduced in the CD38-null mice at a circadian time paralleling with elevated NAD
+ 
levels. Thus, CD38 contributes to behavioral and metabolic circadian rhythms and altered NAD
+ levels influence the 
circadian clock. 
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plasma [10], perhaps contributing to the oscillations in 
NAD
+ levels. NAD
+ is a cofactor and /or substrate for 
over  300  enzymes  and  acts  as  a  cellular  energy 
currency. SIRT1 is one such enzyme whose deacetylase 
activity  is  NAD
+-dependent  [11].  In  addition, 
poly(ADP-ribose)  polymerase  (PARP)-1  and  PARP-2 
are NAD
+-consuming enzymes, and their deletion raises 
NAD
+ levels in mice [12,13]. Moreover, the SIRT1 and 
PARPs systems have been linked as they possibly use 
the  same  NAD
+  cellular  pool  [14].  Circadian 
oscillations  in  NAD
+  levels  drive  SIRT1  rhythmic 
activity [4]. SIRT1, in turn, is recruited to the Nampt 
promoter along with CLOCK and BMAL1. Thus, the 
circadian  machinery  is  regulated  by  an 
enzymatic/transcriptional  feedback  loop,  wherein 
SIRT1 regulates the levels of its own coenzyme [8,9]. 
Interestingly, PARP-1 activity has also been shown to 
display  circadian  oscillation  [15].  These  findings 
highlight the intimate connections between the circadian 
clock and cellular metabolism [16]. 
 
 
 
 
 
 
 
 
 
Since the clock machinery controls the cyclic levels of 
NAD
+,  we  wondered  about  the  importance  of  this 
oscillation  with  respect  to  circadian  function.  We 
thereby  questioned  whether  an  imbalance  of  NAD
+ 
levels in animals with an intact clock system would lead 
to defects in circadian rhythms. To test this hypothesis, 
we analyzed the circadian behavior and metabolism of 
CD38-deficient  (KO)  mice  which  display  very  high 
levels of NAD
+ in tissues such as the brain and liver 
[17,18]. CD38 is a membrane protein that has multiple 
enzymatic activities [19], the major being the hydrolysis 
of  NAD
+,  through  which  it  controls  cellular  NAD
+ 
levels [20,21]. CD38 is also present on the inner nuclear 
membrane  and  regulates  SIRT1  activity  through 
modulation of NAD
+ levels [17,22]. SIRT1 activity is 
higher in the CD38-KO mice [22]. Interestingly, CD38-
KO mice are resistant to high-fat diet-induced obesity, 
in part through the activation of the SIRT1-PGC1α axis 
[23]. Our present study shows that chronically elevated 
levels of NAD
+ in CD38-null mice lead to modulation 
of  the  circadian  clock  illustrated  by  altered  circadian 
behavior,  clock  gene  expression  and  amino  acid 
metabolism. 
 
RESULTS 
 
Altered circadian NAD
+ levels in CD38-null mice.  It 
has been reported that the CD38-KO mice have elevated 
levels of NAD
+ in most tissues [17,18]. We analyzed 
the  profile  of  NAD
+  levels  throughout  the  circadian 
cycle. NAD
+ levels were measured at various zeitgeber 
times (ZTs) and were found to oscillate in the liver as 
described [9] (Fig. 1A). The oscillation of NAD
+ was 
significantly  altered  in  the  liver  of  CD38-KO  mice, 
being much higher than in WT mice at ZT7 and ZT15, 
with  unchanged  levels  at  ZT23  (Fig.  1A).  Most 
remarkably, NAD
+ levels in the CD38-KO mice were 
about 5 times higher than in WT animals at ZT15. Next, 
we  wanted  to  determine  whether  the  differences  in 
NAD
+  levels between WT and CD38-KO mice may be 
due to a change in NADase activity. Indeed, NADase 
activity in the liver of CD38-KO mice was drastically 
lower as compared to the WT animals at ZT7 and ZT15 
(Fig 1B; ref. 13). Surprisingly, CD38-KO mice display 
high  level  of  NADase  activity  (~50%  of  the  WT 
activity) at ZT23. While the reasons for this could be 
due to a time-specific increase in the expression/activity 
of  another  unrecognized  NAD
+  glycohydrolase,  this 
result explains the comparable NAD
+ levels at ZT23.  
 
CD38-KO  mice  display  a  shorter  period  length  of 
locomotor  activity.  The  deregulation  of  NAD
+ 
oscillation  in  the  CD38-KO  mice  prompted  us  to 
monitor  the  circadian  behavior  of  these  mice.  We 
analyzed the period length (tau) of locomotor activity 
under  constant  conditions.  After  entrainment  on  a  12 
hour Light: 12 hour Dark (LD) cycle for more than 3 
weeks,  CD38  WT  and  KO  mice  were  transferred  to 
constant darkness (DD, free running) starting at the time 
of lights “off”, (ZT 12). This day was defined as day 1. 
We  used  passive  (pyroelectric)  infrared  sensors  to 
Figure 1. Effect of CD38 on NAD
+ levels. WT and CD38 KO 
mice entrained in 12 hr Light  –  12 hr Dark (LD)  cycles were 
sacrificed at indicated times and their liver was dissected out. 
(A) NAD
+ concentration was measured by a cycling enzymatic 
assay. *, p<0.05 (WT vs KO ZT7); **, p<0.001 (WT vs KO ZT 15) 
[n=3 each time point] (B) NADase activity was measured by a 
flurometric assay. **, p<0.001 (WT vs KO for each time point) 
[n=3 each time point]. 
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measure period length (tau) [24]. While the WT mice 
displayed  a  tau  of  23.92  hours,  the  CD38-KO  mice 
displayed a tau of 23.80 hours (Fig 2A, B). While this is 
a relatively small difference in tau (about 7 minutes), it 
is highly significant (P = 0.008, n=6, 8). 
 
To establish whether WT and CD38-KO mice differed 
in the resetting responses to light, mice entrained to a 
LD cycle for several weeks were exposed to an 8 hr 
extension  of  the  light  period,  followed  by  constant 
darkness.  A  phase  delay  is  expected  when  mice  are 
exposed to light during this period of night (ZT 12-20). 
Both WT and CD38-KO mice showed a similar phase 
angle of ~ 4 hr; however, the CD38-null mice displayed 
a further shortening of the period length to 23.75 hours, 
compared to 23.94 hours displayed by WT mice after 
the phase extension (Fig S1 A,B). These results indicate 
that the CD38-deficient animals have normal resetting 
responses to light, while their tau is shorter. 
 
Altered rest/activity rhythms in the CD38-null mice. 
While  monitoring  locomotor  activity  of  the  WT  and 
CD38-KO mice, we noticed a marked difference in their 
rest/activity  patterns.  The  WT  mice  displayed  a 
significant break from activity during the middle of the 
night; however, CD38-null mice did not appear to take 
this break (Fig. 2C, area over the striped bar). Instead, 
CD38-KO  mice  appeared  to  take  multiple  breaks, 
randomly  spread  throughout  the  day.  Quantitation  of 
this difference in activity revealed that while WT mice 
Figure 2. Circadian defects in the behavioral rhythm of CD38-KO mice. (A) Representative activity records (actograms) of 
Wild type (CD38
+/+) and CD38 knockout (CD38
-/-) mice are shown in double plotted format. Mice were entrained in 12 hr Light – 12 
hr Dark cycles (LD) and then placed in constant darkness (DD) from the light off (ZT12), on day 1. (B) Bar graph representing the 
period length of WT and CD38-KO mice. Measurement of the free-running period was based on the onset of activity in DD. Data is 
represented as mean ± S.E.  * *, p = 0.008, n= 6, 8. (C) Representative actograms of Wild type (CD38
+/+) and CD38 knockout (CD38
-
/-) mice in LD cycle. (D) Bar graph representing % daily locomotor activity in a one-hour period at the indicated ZTs. Data represents 
mean ± S.E of 10 days of activity. *, p < 0.05; **, p<0.01 compared to the corresponding wild type, n= 6, 8. (E) Representative 
actograms  from  wheel  running  activity  of  Wild  type  (CD38
+/+)  and  CD38  knockout  (CD38
-/-)  mice  in  LD  cycle.  (F)  Bar-graph 
representing total number of wheel rotations per day. Data is represented as mean ± S.E.  **, p = 0.008, n= 6, 5.  
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decrease their locomotor activity significantly between 
ZT20  and  ZT22,  CD38-null  mice  maintained  almost 
constant  levels  of  activity  throughout  the  night  (Fig. 
2D). Significant differences in activity levels were also 
detected at several times during the circadian cycle. The 
differential  activity  pattern  persists  even  under  free 
running conditions (compare the actograms in Fig. 2A). 
 
Analysis  of  the  actograms  indicated  that  the  total 
locomotor  activity  in  the  CD38-KO  mice  might  be 
lower  than  their  WT  counterparts.  To  accurately 
quantitate  total  locomotor  activity,  wheel-running 
activity was monitored. The actograms from the wheel-
running analysis demonstrated that the CD38-KO mice 
have  reduced  locomotor  activity  (Fig.  2E).  Total 
locomotor activity is reduced by ~3 fold in the CD38-
KO  mice,  compared  to  the  WT  mice  (Fig.  2F).  The 
alterations in the rest/activity rhythms observed by the 
passive  infrared  sensors  were  also  detected  in  the 
wheel-running  activity.  While  WT  mice  took  a  break 
from wheel running only during a small period at late 
night,  the  CD38-KO  mice  took  intermittent  breaks. 
These results demonstrate that the rest/activity rhythm 
is disturbed in the CD38-deficient mice.  
 
Ablation  of  CD38  results  in  disturbances  in  the 
peripheral clockwork. The behavioral analysis of the 
CD38-KO mice indicates that deregulated and elevated 
levels of NAD
+ alter central clock functions. To address 
whether  peripheral  clock  function  is  also  affected  by 
deregulated  NAD
+  levels,  we  analyzed  the  circadian 
gene  expression  of  representative  clock  genes  from 
liver. WT and CD38-KO mice were entrained to a 12 hr 
LD cycle and livers were harvested at various circadian 
times. As shown in Fig. 3A, the amplitude of circadian 
gene  expression  of  Dbp,  Per2  and  Nampt  is 
significantly  higher  in  CD38-null  than  in  WT  mice, 
with  most  divergent  levels  at  ZT7.  These  results 
indicate  that  peripheral  clock  is  also  affected  by 
elevated NAD
+ levels. 
 
To  establish  if  circadian  metabolic  pathways  are 
influenced by deregulation of NAD
+ in the CD38-KO 
mice,  we  performed  a  microarray  analysis.  Entrained 
WT  and  CD38-KO  mice  were  sacrificed  at  two 
circadian  times  (ZT9  and  ZT  21),  and  liver  mRNAs 
were  used  for  microarray  analysis.  Among  the  genes 
that are differentially regulated between WT and CD38-
KO mice (Table S1), we validated 4 genes which were 
upregulated in the mutant mice (Fig. 3B). These genes 
were Asparagine Synthetase (Asns); Insulin-like growth 
factor  binding  protein  1  (Igfbp1);  c-Myc;  and 
monooxygenase,  DBH-like  1  (Moxd1).  Among  these 
genes, c-Myc and Igfbp1 have been shown to display a 
Figure 3. Differential liver gene expression in CD38-null mice. Mice entrained in 12 hr 
Light – 12 hr Dark cycles were sacrificed at indicated times and their liver was dissected out. (A) 
RNA was prepared at indicated times, reverse transcribed, and real-time PCR was performed 
using primers for Dbp, Per2, Nampt and 18S rRNA. Data is represented as relative levels of 
indicated gene normalized to 18S rRNA. (B) Same as in (A), except real-time PCR was performed 
using primers for  Asns, Igfbp1, Moxd1 and c-Myc. Data is represented as relative levels of 
indicated gene normalized to 18S rRNA. *, p<0.05 compared to the corresponding wild type, n= 
3 each time point. 
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circadian profile of expression [25,26]. While Asns and 
Moxd1  were  elevated  at  both  ZTs  in  the  CD38-KO 
mice, c-Myc and Igfbp1 elevation is more pronounced at 
ZT9  and  ZT 21,  respectively  (Fig.  3B).  Interestingly, 
SIRT1  might  be  involved  in  the  regulation  of  Asns 
expression. SIRT1 activity highly correlates with Asns 
expression  levels:  Asns  levels  are  high  in  CD38-KO 
mice  (where  the  SIRT1  activity  is  high);  and, 
conversely,  Asns  expression  levels  are  very  low  in 
SIRT1 liver-specific KO mice (Fig. S2A).  
 
 
 
 
 
 
 
 
 
 
 
The  expression  of  Asns  and  Igfbp1  is  known  to  be 
upregulated under conditions of amino acid deprivation 
[27-29].  We  verified  that  the  Asns  promoter  is 
responsive  to  amino  acid  starvation.  Indeed,  Asns-
promoter  driven  luciferase  activity  was  induced  over 
six-fold  after  amino  acid  depletion  (Fig.  S2B).  Since 
most amino acids display a circadian profile in mouse 
plasma  [10],  these  results  prompted  us  to  evaluate 
whether  the  circadian  regulation  of  amino  acid 
metabolism  might  be  dependent  on  the  presence  of 
CD38. 
 
Alterations  in  the  plasma  amino  acid  levels  in  the 
CD38-KO mice.  We performed a metabolomic study 
to determine the plasma amino acid levels in WT and 
CD38-KO mice along the circadian cycle, according to 
the method described by Lanza et. al. [30].  Most amino 
acid levels oscillated in a pattern consistent with that 
recently described by Minami et. al. [10]. We observed 
significant changes in the amino acid levels between the 
WT  and  the  CD38-KO  mice,  at  different  circadian 
times. Four amino acids (Tryptophan, Hydroxyproline, 
Tyrosine,  and  β-Alanine)  displayed  significantly 
reduced  levels  at  one  or  more  circadian  time  in  the 
plasma of CD38-KO mice (Fig. 4). On the other hand, 
four  amino  acids  (Asparagine,  Glycine,  Histidine  and 
Methionine)  displayed  higher  levels  in  the  CD38-KO 
mice  (Fig.  4).  These  results  demonstrate  that  the 
circadian  oscillations  in  amino  acids  levels  are 
compromised  in  the  CD38  KO  mice,  thereby 
establishing a direct link between specific amino acid 
metabolic pathways and controlled NAD
+ levels.  
 
DISCUSSION 
 
Our current work has addressed the question whether 
alterations in NAD
+ rhythmicity in vivo could affect the 
functioning  of  central  and  peripheral  clocks.  For  this 
purpose we explored the circadian behavior of CD38-
KO  mice  which  have  elevated  NAD
+  levels.  We 
observed that oscillations in NAD
+ levels were altered 
in the liver of CD38-KO mice. Strikingly, at ZT 15 (the 
trough  of  NAD
+  levels  in  WT  liver),  NAD
+  levels 
peaked in CD38-KO mice and were ~ 5 times higher 
than those in the liver of WT mice. Surprisingly, NAD
+ 
levels were similar between WT and CD38-KO mice at 
ZT23. This could be due to an increase at this circadian 
time of NADase activity in CD38-null mice. Although 
CD38  is  the  major  NAD
+  hydrolase  in  cells,  it  is 
possible  that  in  its  absence  other  NAD
+  hydrolases 
(such as CD157, a gene duplication product of CD38) 
could be induced as a compensatory mechanism. 
 
CD38  also  plays  a  role  in  the  synthesis  of  second 
messengers cyclic ADP-Ribose (cADPR), ADPR, and 
nicotinic  acid  adenine  dinucleotide  phosphate 
(NAADP)  [19].  CD38  can  produce  one  molecule  of 
cADPR for every 100 molecules of NAD
+ hydrolyzed 
[21,31], suggesting that the major enzymatic activity of 
CD38  is  the  hydrolysis  of  NAD
+.    CD38  regulates 
Figure 4. Alterations in the plasma amino acid levels in 
CD38-KO mice. Mice Mice were entrained in 12 hr Light – 12 
hr Dark cycles and blood was drawn at indicated times. Amino 
acid levels in plasma were determined as described in Materials 
and Methods. Amino acids that displayed statistically significant 
differences in abundance between the wild type and the CD38-
KO mice are shown here. *, p<0.05; **, p<0.01 compared to the 
corresponding wild type, n= 3 each time point. 
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SIRT1  through  a  cADPR  independent  pathway  [23]. 
Acetylation  of  several  SIRT1  targets,  such  as p53,  is 
reduced in the CD38-KO mice [22,23], and CLOCK-
induced  BMAL1  acetylation  is  enhanced  by  ectopic 
expression  of  CD38,  possibly  through  modulation  of 
SIRT1  activity  (Fig.  S3).    In  keeping  with  this 
observation, several circadian behavioral defects were 
observed  in  the  CD38-KO  mice.  Their  free-running 
period  length  is  ~  7  minutes  shorter  than  the  WT 
animals.  Although  this  difference  may  appear  small, 
deletion of CLOCK, the master regulator of circadian 
rhythms, changes the period length by only 20 minutes 
[32];  and  mutants  in  NPAS2  (a  paralog  of  CLOCK 
highly expressed in the brain) show only a 12 minute 
shortening in period length [33]. Interestingly, CD38-
null  mice  displayed  an  altered  pattern  of  rest/activity 
rhythm, reminiscent of that reported for NPAS2 mutant 
mice  [33].  WT  mice  on  a  C57/BL6  background  are 
known to take a break at late night (ZT 20-22), which 
generally corresponds to a short nap [33]. Both CD38-
null mice and NPAS2 mutant mice remain active at that 
time. However, differently from NPAS2 mutant mice, 
CD38-deficient mice appear to keep taking intermittent 
breaks  throughout  the  day.  Moreover,  the  total 
locomotor  activity  of  CD38-null  mice  is  also 
significantly lower. This reduction in locomotor activity 
could be attributed to increased SIRT1 activity in the 
CD38-KO  mice  (17),  since  transgenic  mice 
overexpressing  SIRT1  display  a  similar  reduction  in 
locomotor activity [34]. The altered rest/activity rhythm 
in the CD38-KO mice does not seem to be caused by 
defects in the motivation for running. These mice took 
several breaks from running and kept running at regular 
intervals. This behavior could potentially be described 
as a fatigue syndrome. Further studies are required to 
prove this hypothesis. 
 
The  central  circadian  clock  is  located  in  the 
suprachiasmatic  nucleus  (SCN)  of  the  hypothalamus, 
while peripheral clocks are present in most organs [35]. 
We  have  shown  that  ablation  of  CD38  results  in 
elevated  levels  of  NAD
+  in  the  liver,  leading  to 
perturbation  in  clock  function.  The  stringency  of 
circadian oscillation is compromised in the absence of 
CD38, as demonstrated by the gene expression profiles 
of Dbp, Per2 and Nampt. The deregulation of circadian 
gene  expression  extends  to  several  genes  involved  in 
amino  acid  metabolism,  which  we  found  to  be 
upregulated in the liver of CD38-deficient mice. These 
genes were Asparagine synthetase (Asns); Insulin-like 
growth  factor binding  protein  1  (Igfbp1);  c-Myc;  and 
monooxygenase,  DBH-like  1  (Moxd1).  The  liver  is  a 
major  organ  involved  in  the  amino  acid  metabolism. 
Nutritional stresses, such as reduced availability of an 
amino acid, can initiate a signaling cascade referred to 
as the amino acid response (AAR) pathway [29]. Asns 
and Igfbp1 are genes that are known to be upregulated 
by the AAR pathway. Asparagine synthetase converts 
amino acids aspartate and glutamine into asparagine and 
glutamate.  Interestingly,  SIRT1  activity  positively 
correlates with Asns expression levels. SIRT1 has also 
been  shown  to  induce  the  expression  of  Igfbp1  [36].  
Low  Igfbp1  levels  are  considered  to  be  markers  of 
metabolic  syndrome  [37]  and  the  Igfbp1  transgenic 
mice  are  protected  from  diet-induced  obesity  [38],  a 
trait  shared  by  the  CD38-null  mice  [23].  c-MYC, 
besides having the well characterized role in cell cycle 
regulation, also regulates glutaminolysis [39]. MOXD1 
is  a  monoxygenase  with  a  yet  unidentified  function; 
however,  monooxygenses  are  known  to  regulate 
conversion  of  one  amino  acid  into  another  (e.g. 
phenylalanine hydroxylase, a monooxygenase, converts 
phenylalanine to tyrosine). It is interesting to speculate 
that MOXD1 might also function in inter-conversion of 
amino  acids  and  is  upregulated  under  conditions  of 
deficiency of a subset of amino acids.  
 
A metabolomic analysis confirmed our hypothesis that 
circadian oscillations in amino acid levels are disrupted 
in the absence of CD38. Levels of tryptophan, tyrosine, 
hydroxyproline and β-alanine were found to be reduced 
in  CD38-null  mice,  whereas  asparagine,  glycine, 
histidine  and  methionine  were  elevated.  Moreover, 
oscillations  in  most  of  these  amino  acids  were 
dampened in mutant mice. Changes in asparagine and 
tryptophan  levels  are  of  special  interest.  Since  Asns 
levels are higher in CD38-null mice, we predicted that 
asparagine  levels  would  also  be  higher.  Surprisingly, 
asparagine levels were high only at ZT7, although Asns 
expression  was  constitutively  higher  in  mutant  mice. 
This suggests that ASNS activity might be modulated in 
a circadian manner. As tryptophan is a source for NAD
+ 
biosynthesis, it is intriguing that levels of NAD
+ were 
very  high  and  levels  of  tryptophan  were  significantly 
reduced  at  ZT15  in  CD38-null  mice,  alluding  to  the 
consumption of tryptophan during NAD
+ biosynthesis. 
Finally, it can be concluded that the altered levels of 
some amino acids might trigger the amino acid response 
pathway in CD38-KO mice. 
 
An  intriguing  speculation  relates  to  the  notion  that 
amino acids and their metabolites can also function as 
neurotransmitters  or  their  precursors.  Glutamate, 
aspartate, glycine and γ-amino butyric acid (GABA) are 
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neurotransmitters.  Tryptophan  is  a  precursor  for 
serotonin,  whereas  tyrosine  is  a  precursor  for 
catecholamines,  such  as  dopamine,  epinephrine  and 
norepinephrine. An imbalance in these amino acids can 
potentially  change  the  concentration  of  certain 
neurotransmitters  in  the  brain.  Further  studies  will 
establish whether changes in these neurotransmitters are 
responsible  for  alterations  in  the  rest/activity  rhythms 
and locomotor activity in the CD38-null mice. 
 
In  conclusion,  our  results  reveal  a  role  for  NAD
+ 
homeostasis and SIRT1 activity in circadian regulation 
of behavioral and metabolic rhythms. Increased NAD
+ 
levels and concomitant activation of SIRT1 might lead 
to reduction in several amino acids, which activates the 
AAR  pathway  in  CD38-null  mice.  Our  findings 
underscore the importance of circadian control in amino 
acid metabolism. 
 
MATERIALS AND METHODS 
 
Animals 
 
Generation  of  CD38-deficient  mice  (C57BL/6J.129 
CD38
−/−,  N12  backcross)  has  been  described  [40]. 
Liver-specific  Sirt1
−/−  mice  have  also  been  described 
[4]. Mice housed in individual cages were entrained on 
a L12:D12 (12 h light–12 h dark) cycle for two weeks 
before  analyses.  Mice  were  sacrificed  at  specified 
circadian  times.  All  research  involving  vertebrate 
animals has been performed under protocol approved by 
the  Institutional  Animal  Care  and  Use  Committee 
(IACUC). Animals are monitored on a daily basis by 
both  the  lab  and  University  Lab  Animal  Resources 
(ULAR)  veterinary  staff  for  signs  of  distress,  pain, 
and/or infection, and are given ad libitum access to food 
and water.  Cages were cleaned on a weekly basis and 
when visibly soiled to maintain a clean environment.  
All  husbandry  procedures  and  welfare  policies  are 
conducted according to the Guide for the Care and Use 
of  Laboratory  Animals,  set  forth  by  the  Institute  of 
Laboratory  Animal  Resources,  Commission  on  Life 
Sciences, and National Research Council. 
 
NAD
+ measurements 
 
 NAD
+  was  measured  as  described  previously  [17]. 
Briefly, frozen tissue was pulverized with a pestle and 
mortar in liquid nitrogen, immediately extracted in ice-
cold  10%  trichloroacetic  acid  (sigma)  and  sonicated 
with 3 pulses of 3 seconds. After a short centrifugation 
the  supernatant  was  extracted  with  2  volumes  of  a 
combination  of  1,1,2-trichloro-1,2,2-trifluroethane  : 
trioctylamine  in  a  3  to  1  ratio.  The  samples  were 
vigorously  vortexed  and  2  phases  were  allowed  to 
separate at room temperature. The pH of the extracted 
aqueous layer containing the NAD
+ was adjusted with 
1M Tris pH 8. The NAD
+ concentration was measured 
by a cycling enzymatic assay. The samples were diluted 
in  100  mM  NaH2PO4,  pH  8  and  incubated  with  a 
solution  containing  0.76%  ethanol;  4  μM  flavine 
mononucleotide; 40 μg/ml alcohol dehydrogenase; 0.04 
U/ml diaphorase; and 8 μM resazurin in buffer 100 mM 
NaH2PO4,  pH  8.  The  fluorescence  (excitation  544, 
emission  590)  was  monitored  over  time  in  a 
fluorometric  plate  reader  (Spectramax  Gemini  XPS, 
Molecular  devices).  A  NAD
+  standard  curve  was 
performed  using  yeast  NAD
+  (sigma).  NAD
+ 
concentration was expressed as pmol per mg of tissue. 
 
NADase activity 
 
The NADase activity in liver samples was measured as 
described  previously  [17].  Frozen  liver  samples  were 
homogenized in sucrose 0.25M - Tris 40mM, pH 7.4 
buffer supplemented with protease inhibitors (Roche), 
and  centrifuged  10  minutes  at  11200  g.  200  µg  of 
homogenate  was  incubated  with  100  µM  of  1,N
6-
etheno-adenine dinucleotide (etheno-NAD)(Sigma) and 
the fluorescence was measured in a fluorometric plate 
reader  (Spectramax  Gemini  XPS,  Molecular  devices). 
The  change  in  fluorescence  over  time  (excitation 
300nm, emission 410) was followed and the NADase 
activity  was  expressed  as  the  change  in  the  arbitrary 
units of fluorescence per second per mg of protein.  
 
Analysis of behavioral rhythms 
 
Circadian rhythms in locomotor activity was analyzed 
as  described  [24].  Briefly,  locomotor  activity  was 
detected  using  running  wheels  and  passive 
(pyroelectric)  infrared  sensors  (PU-2201;  EK  Japan). 
Locomotion  data  were  collected  using  the  VitalView 
data acquisition system (Mini-Mitter) using a sampling 
interval  of  5  min.  Actograms  were  acquired  using 
Actiview Biological Rhythm Analysis software (Mini-
Mitter). Circadian period and phase shift of the activity 
rhythms  were  analyzed  by  Clocklab  software 
(Actimetrics). 
 
Quantitative Real-Time RT-PCR 
 
Each  quantitative  real-time  RT-PCR  was  performed 
using  the  PTC-200  real  time  detection  system  (MJ 
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Research). The PCR primers are available upon request. 
For a 20 µl PCR, 50 ng of cDNA template was mixed 
with the primers to final concentrations of 200 nM and 
10  µl  of  iQ  SYBR  Green  Supermix  (BIO-RAD), 
respectively. The reaction was first incubated at 95
0C 
for 3 min, followed by 40 cycles at 95
0C for 30 s and 
60
0C for 1 min. 
 
Luciferase assays 
 
Hepa1c1c7 cells (ATCC, Manassas, VA) were cultured 
in  Minimal  Essential  Media  supplemented  with  10% 
FBS  and  antibiotics.  Cells  growing  in  24-well  plates 
were  transfected  with  indicated  plasmids  using  BioT 
transfection reagent (Bioland Scientific LLC, Cerritos, 
CA)  according  to  manufacturer’s  recommendations. 
Plasmid  expressing  3.4  kb  ASNS-promoter-driven 
luciferase was a gift from Dr. Pierre Fafournoux [41]. 
The total amount of DNA applied per well was adjusted 
by adding an empty vector. Cell extracts were subjected 
to luminometry-based-luciferase assay (Promega), and 
luciferase  activity  was  normalized  by  β-galactosidase 
activity.  All  experiments  were  performed  in  multiple 
replicates. 
 
Amino acid analysis 
 
Amino  acid  concentrations  in  plasma  samples  were 
determined at the Metabolomics facility at Mayo Clinic 
College of Medicine, Rochester, Minnesota according 
to the method described by Lanza et. al. [30]. Briefly, 
plasma  samples  were  deproteinized  with  cold  MeOH 
prior  to  derivatization  using  6-aminoquinolyl-N-
hydroxysuccinimidyl  carbamate.  Amino  acid  levels 
were then determined by LC-MS/MS. 
 
Data Analyses 
 
Results  are  expressed  as  means  ±  SE  of  multiple 
experiments.
  Student  t  tests  were  used  to  compare  2 
groups or ANOVA with
 the Bonferroni post tests for 
multiple  groups  using  Prism
  software  (Graph  Pad). 
Statistical significance was detected
 at the 0.05 level. 
 
ACKNOWLEDGEMENTS 
 
We would like to thank all the members of the Sassone-
Corsi  and  Chini  laboratories  for  reagents  and  helpful 
discussions. We also wish to express our gratitude to 
Dr. Satoru Masubuchi and Dr. Kristin Eckel-Mahan for 
help  with  behavioral  analysis.  This  research  was 
supported  by  grants  from  the  National  Institutes  of 
Health  (R01-GM081634),  the  Institut  National  de  la 
Sante  et  de  la  Recherche  Medicale  [INSERM-44790] 
(France),  and  Sirtris  Pharmaceutical  Inc.  to  PSC  and 
National  Institutes  of  Health  (DK-084055  from 
NIDDK), the American Federation for Aging Research, 
the  Mayo  Foundation  and  by  the  Strickland  Career 
Development Award to ENC. 
 
CONFLICT OF INTEREST STATEMENT 
 
The authors declare no conflicts of interest. 
 
REFERENCES 
 
1.  Sahar  S,  Sassone-Corsi  P.  Metabolism  and  cancer:  The 
circadian clock connection. Nat Rev Cancer 2009;9:886-896. 
2. Takahashi JS, Hong HK, Ko CH, McDearmon EL. The genetics of 
mammalian  circadian  order  and  disorder:  Implications  for 
physiology and disease. Nat Rev Genet 2008;9:764- 775. 
3.  Gallego  M,  Virshup  DM.  Post-translational  modifications 
regulate the ticking of  the circadian clock. Nat Rev  Mol.  Cell. 
Biol.2007;8:139-148. 
4. Nakahata Y, Kaluzova M, Grimaldi B, Sahar S, Hirayama J, Chen 
D,  Guarente  LP,  Sassone-Corsi  P.  The  nad+-dependent 
deacetylase  sirt1  modulates  clock-mediated  chromatin 
remodeling and circadian control. Cell 2008;134:329-340. 
5. Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel 
F, Mostoslavsky R, Alt FW, Schibler U. Sirt1 regulates circadian 
clock  gene  expression  through  per2  deacetylation.  Cell 
2008;134:317-328. 
6. Doi M, Hirayama J, Sassone-Corsi P. Circadian regulator clock 
is a histone acetyltransferase. Cell 2006;125:497-508. 
7.  Hirayama  J,  Sahar  S,  Grimaldi  B,  Tamaru  T,  Takamatsu  K, 
Nakahata  Y,  Sassone-Corsi  P.  Clock-mediated  acetylation  of 
bmal1 controls circadian function. Nature 2007;450:1086-1090. 
8. Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P. 
Circadian  control  of  the  nad+  salvage  pathway  by  clock-sirt1. 
Science 2009;324:654-657. 
9. Ramsey KM, Yoshino J, Brace CS, Abrassart D, Kobayashi Y, 
Marcheva B, Hong HK, Chong JL, Buhr ED, Lee C, Takahashi JS, 
Imai S, Bass J. Circadian clock feedback cycle through nampt-
mediated nad+ biosynthesis. Science 2009;324:651-654. 
10. Minami Y, Kasukawa T, Kakazu Y, Iigo M, Sugimoto M, Ikeda 
S, Yasui A, van der Horst GT, Soga T, Ueda HR. Measurement of 
internal body time by blood metabolomics. Proceedings of the 
National Academy of Sciences of the United States of America 
2009;106:9890-9895. 
11.  Imai  S,  Armstrong  CM,  Kaeberlein  M,  Guarente  L. 
Transcriptional  silencing  and  longevity  protein  sir2  is  an  nad-
dependent histone deacetylase. Nature 2000;403:795-800. 
12. Bai P, Canto C, Oudart H, Brunyanszki A, Cen Y, Thomas C, 
Yamamoto H, Huber A, Kiss B, Houtkooper RH, Schoonjans K, 
Schreiber V, Sauve AA, Menissier-de Murcia J, Auwerx J. Parp-1 
inhibition  increases  mitochondrial  metabolism  through  sirt1 
activation. Cell metabolism 2011;13:461-468. 
13. Bai P, Canto C, Brunyanszki A, Huber A, Szanto M, Cen Y, 
Yamamoto  H,  Houten  SM,  Kiss  B,  Oudart  H,  Gergely  P, 
Menissier-de Murcia J, Schreiber V, Sauve AA, Auwerx J. Parp-2 
   
www.impactaging.com                      8                   AGING, August 2011, Vol.3 No.8  
regulates sirt1 expression and whole-body energy expenditure. 
Cell metabolism 2011;13:450-460. 
14. Kolthur-Seetharam U, Dantzer F, McBurney MW, de Murcia 
G,  Sassone-Corsi  P.  Control  of  aif-mediated  cell  death  by  the 
functional  interplay  of  sirt1  and  parp-1  in  response  to  DNA 
damage. Cell cycle 2006;5:873-877. 
15.  Asher  G,  Reinke  H,  Altmeyer  M,  Gutierrez-Arcelus  M, 
Hottiger  MO,  Schibler  U.  Poly(adp-ribose)  polymerase  1 
participates  in  the  phase  entrainment  of  circadian  clocks  to 
feeding. Cell 2010;142:943-953. 
16. Eckel-Mahan K, Sassone-Corsi P. Metabolism control by the 
circadian  clock  and  vice  versa.  Nature  structural  &  molecular 
biology 2009;16:462-467. 
17. Aksoy P, White TA, Thompson M, Chini EN.  Regulation of 
intracellular levels of nad: A novel role for cd38. Biochemical and 
biophysical research communications 2006;345:1386-1392. 
18. Young GS, Choleris E, Lund FE, Kirkland JB. Decreased cadpr 
and  increased  nad+  in  the  cd38-/-  mouse.  Biochemical  and 
biophysical research communications 2006;346:188-192. 
19. Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, 
Ortolan E, Vaisitti T, Aydin S. Evolution and function of the adp 
ribosyl cyclase/cd38 gene family in  physiology and pathology. 
Physiological reviews 2008;88:841-886. 
20. Hoshino S, Kukimoto I, Kontani K, Inoue S, Kanda Y, Malavasi 
F, Katada T. Mapping of the catalytic and epitopic sites of human 
cd38/nad+ glycohydrolase to a functional domain in the carboxyl 
terminus. J Immunol 1997;158:741-747. 
21.  Chini  EN.  Cd38  as  a  regulator  of  cellular  nad:  A  novel 
potential  pharmacological  target  for  metabolic  conditions. 
Current pharmaceutical design 2009;15:57-63. 
22.  Aksoy  P,  Escande  C,  White  TA,  Thompson  M,  Soares  S, 
Benech  JC,  Chini  EN.  Regulation  of  sirt  1  mediated  nad 
dependent deacetylation: A  novel role for the multifunctional 
enzyme  cd38.  Biochemical  and  biophysical  research 
communications 2006;349:353-359. 
23.  Barbosa  MT, Soares SM,  Novak CM, Sinclair D,  Levine JA, 
Aksoy P, Chini EN. The enzyme cd38 (a nad glycohydrolase, ec 
3.2.2.5)  is  necessary  for  the  development  of  diet-induced 
obesity. Faseb J 2007;21:3629-3639. 
24. Masubuchi S, Gao T, O'Neill A, Eckel-Mahan K, Newton AC, 
Sassone-Corsi P. Protein phosphatase phlpp1 controls the light-
induced  resetting  of  the  circadian  clock.  Proceedings  of  the 
National  Academy  of  Sciences  of  the  United  States  of 
America;107:1642-1647. 
25. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene 
period2 plays an important role in tumor suppression and DNA 
damage response in vivo. Cell 2002;111:41-50. 
26. Hou TY, Ward SM, Murad JM, Watson NP, Israel MA, Duffield 
GE. Id2 (inhibitor of DNA binding 2) is a rhythmically expressed 
transcriptional repressor required for circadian clock output in 
mouse  liver.  The  Journal  of  biological  chemistry 
2009;284:31735-31745. 
27.  Gong  SS,  Guerrini  L,  Basilico  C.  Regulation  of  asparagine 
synthetase gene expression by amino acid starvation. Molecular 
and cellular biology 1991;11:6059-6066. 
28.  Straus  DS,  Burke  EJ,  Marten  NW.  Induction  of  insulin-like 
growth  factor  binding  protein-1  gene  expression  in  liver  of 
protein-restricted rats and in rat hepatoma cells limited for a 
single amino acid. Endocrinology 1993;132:1090-1100. 
29.  Kilberg  MS,  Pan  YX,  Chen  H,  Leung-Pineda  V.  Nutritional 
control of gene expression: How mammalian cells respond to 
amino acid limitation. Annual review of nutrition 2005;25:59-85. 
30. Lanza IR, Zhang S, Ward LE, Karakelides H, Raftery D, Nair KS. 
Quantitative  metabolomics  by  h-nmr  and  lc-ms/ms  confirms 
altered metabolic pathways in diabetes.  PloS one;5:e10538. 
31. Kim H, Jacobson EL, Jacobson MK. Synthesis and degradation 
of  cyclic  adp-ribose  by  nad  glycohydrolases.  Science 
1993;261:1330-1333. 
32. Debruyne JP, Noton E, Lambert CM, Maywood ES, Weaver 
DR, Reppert SM. A clock shock: Mouse clock is not required for 
circadian oscillator function. Neuron 2006;50:465-477. 
33. Dudley CA, Erbel-Sieler C, Estill SJ, Reick M, Franken P, Pitts S, 
McKnight  SL.  Altered  patterns  of  sleep  and  behavioral 
adaptability in npas2-deficient mice. Science 2003;301:379-383. 
34. Banks AS, Kon N, Knight C, Matsumoto M, Gutierrez-Juarez 
R,  Rossetti  L,  Gu  W,  Accili  D.  Sirt1  gain  of  function  increases 
energy efficiency and prevents diabetes in mice. Cell metabolism 
2008;8:333-341. 
35. Schibler U, Sassone-Corsi P. A web of circadian pacemakers. 
Cell 2002;111:919-922. 
36.  Gan  L,  Han  Y,  Bastianetto  S,  Dumont  Y,  Unterman  TG, 
Quirion  R.  Foxo-dependent  and  -independent  mechanisms 
mediate  sirt1  effects  on  igfbp-1  gene  expression.  Biochemical 
and biophysical research communications 2005;337:1092-1096. 
37. Ruan W, Lai M: Insulin-like growth factor binding protein. A 
possible  marker  for  the  metabolic  syndrome?  Acta 
diabetologica;47:5-14. 
38. Rajkumar K, Modric T, Murphy LJ. Impaired adipogenesis in 
insulin-like growth factor binding protein-1 transgenic mice. The 
Journal of endocrinology 1999;162:457-465. 
39. Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, 
Pfeiffer  HK,  Nissim  I,  Daikhin  E,  Yudkoff  M,  McMahon  SB, 
Thompson CB. Myc regulates a transcriptional         program that 
stimulates mitochondrial glutaminolysis and leads to glutamine 
addiction. Proceedings of the National Academy of Sciences of 
the United States of America 2008;105:18782-18787. 
40. Cockayne DA, Muchamuel T, Grimaldi JC, Muller-Steffner H, 
Randall TD, Lund FE, Murray R, Schuber F, Howard MC. Mice 
deficient  for  the  ecto-nicotinamide  adenine  dinucleotide 
glycohydrolase cd38 exhibit altered humoral immune responses. 
Blood 1998;92:1324-1333. 
41. Bruhat A, Averous J, Carraro V, Zhong C, Reimold AM, Kilberg 
MS,  Fafournoux  P.  Differences  in  the  molecular  mechanisms 
involved  in  the  transcriptional  activation  of  the  chop  and 
asparagine  synthetase  genes  in  response  to  amino  acid 
deprivation or activation of the unfolded protein response. The 
Journal of biological chemistry 2002;277:48107-48114. 
 
SUPPLEMENTAL DATA 
 
The  Supplemental  Information  is  found  in  Full  Text 
version of this manuscript. 
   
www.impactaging.com                      9                   AGING, August 2011, Vol.3 No.8 